Remember me
Liver Int. 2021; 41: 456-463
A micro-elimination approach for HCV was advocated early on to guide efforts towards the achievement of WHO's HCV elimination goals. Due to their disproportionate burden of disease and increased risk of acquiring HCV infection, the prison population has been highlighted for tailored interventions, including active case finding, streamlined linkage to care, and decentralised treatment with direct-acting antiviral (DAA) drugs. 2 Vroling H Oordt-Speets AM Madeddu G et al. A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA.J Viral Hepat. 2018; 25: 1406-1422
, 3 Oru E Trickey A Shirali R Kanters S Easterbrook P Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis.Lancet Glob Health. 2021; 9: e431-e445
Yet, access to HCV care in prisons is not well documented, with a heterogeneous scenario emerging as a result of scarce data on treatment availability and coverage. 4 Nakitanda AO Montanari L Tavoschi L Mozalevskis A Duffell E Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action.BMC Public Health. 2020; 201670
Structural, logistical, management, and sometimes political issues make it difficult to include prison settings in broader public health programmes. The application of evidence-based and data-driven decision making to prison health services, although strongly advocated, 5 UNODCWHO Regional Office for EuropeJ Viral Hepat. 2018; 25: 1406-1422
, 3 Oru E Trickey A Shirali R Kanters S Easterbrook P Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis.Lancet Glob Health. 2021; 9: e431-e445
Comments (0)